Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito, Marta Seijo-Vila, Miriam Caro-Villalobos, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 285-293
Closed Access | Times Cited: 166

Showing 26-50 of 166 citing articles:

Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug
Shiri Procaccia, Gil M. Lewitus, Carni Lipson Feder, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
Plant Growth-Promoting Rhizobacteria (PGPR) with Microbial Growth Broth Improve Biomass and Secondary Metabolite Accumulation of Cannabis sativa L.
Dongmei Lyu, Rachel Backer, Fabrice Berrué, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 19, pp. 7268-7277
Open Access | Times Cited: 17
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Sandra Blasco-Benito, Estefanía Moreno, Marta Seijo-Vila, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 9, pp. 3863-3872
Open Access | Times Cited: 52
Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
Andrea M. Tomko, Lauren O’Leary, Hilary Trask, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 49
The ‘entourage effect’ or ‘hodge-podge hashish’: the questionable rebranding, marketing, and expectations of cannabis polypharmacy
Peter S. Cogan
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 8, pp. 835-845
Closed Access | Times Cited: 48
Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
Marika Heblinski, Marina Santiago, Charlotte Fletcher, et al.
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 4, pp. 305-317
Open Access | Times Cited: 46
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
Luka Dobovišek, Fran Krstanović, Simona Borštnar, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 525-525
Open Access | Times Cited: 42
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
Lyndsey L. Anderson, Maia G. Etchart, Dilara Bahceci, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
Dan Jin, Philippe Henry, Jacqueline J. Shan, et al.
Frontiers in Plant Science (2021) Vol. 12
Open Access | Times Cited: 36
Different Cannabis sativa Extraction Methods Result in Different Biological Activities against a Colon Cancer Cell Line and Healthy Colon Cells
Jan Rožanc, Petra Kotnik, Marko Milojević, et al.
Plants (2021) Vol. 10, Iss. 3, pp. 566-566
Open Access | Times Cited: 35
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
Cristina Ferreira Almeida, Natércia Teixeira, Georgina Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 156-156
Open Access | Times Cited: 33
Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment
Ellen Schanknecht, Ava Bachari, Nazim Nassar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 859-859
Open Access | Times Cited: 14
Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials
Sheik Aliya, Marzieh Ramezani Farani, Eunsu Kim, et al.
Environmental Research (2023) Vol. 231, pp. 115862-115862
Closed Access | Times Cited: 14
Cannabinoids and triple-negative breast cancer treatment
Luka Dobovišek, Simona Borštnar, Nataša Debeljak, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Perspectives on Cannabis as a Substitute for Opioid Analgesics
Sara P. Khan, Thomas A. Pickens, Daniel J. Berlau
Pain Management (2019) Vol. 9, Iss. 2, pp. 191-203
Closed Access | Times Cited: 38
In vivo and in vitro anti-inflammatory activity evaluation of Lebanese Cannabis sativa L. ssp. indica (Lam.)
Wassim N. Shebaby, Jane Saliba, Wissam H. Faour, et al.
Journal of Ethnopharmacology (2020) Vol. 270, pp. 113743-113743
Closed Access | Times Cited: 38
Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles
Ana Isabel Fraguas‐Sánchez, Ana Fernández-Carballido, Florence Delié, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 154, pp. 246-258
Closed Access | Times Cited: 36
Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors
Cristina Amaral, Fabien Marc Trouille, Cristina Ferreira Almeida, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 210, pp. 105876-105876
Closed Access | Times Cited: 29
Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer
Andrea M. Tomko, Erin G. Whynot, Denis J. Dupré
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 22
The chemical composition of ethanolic extracts from six genotypes of medical cannabis (Cannabis sativa L.) and their selective cytotoxic activity
Anežka Janatová, Ivo Doskočil, Matěj Božík, et al.
Chemico-Biological Interactions (2022) Vol. 353, pp. 109800-109800
Closed Access | Times Cited: 20
Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment
Cristiana Dumbraveanu, Katharina Strommer, Meinolf Wonnemann, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 853-853
Open Access | Times Cited: 13
Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines
Erin G. Whynot, Andrea M. Tomko, Denis J. Dupré
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses
Mostafa Yazdan, Seyed Morteza Naghib, M.R. Moepubi
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 12, pp. 896-915
Closed Access | Times Cited: 4
Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines
Saba Omer, Suhrud Pathak, Mahmoud Mansour, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 495-495
Open Access | Times Cited: 4

Scroll to top